The Global One Health initiative (GOHi), in collaboration with the Ethiopian Food and Drug Administration Authority (EFDA), organized a project kickoff and sensitization workshop about adverse events following immunizations (AEFI) in August in Addis Ababa, Ethiopia.
Tagged: Global One Health
GOHi initiated sero-prevalence study on SARS-CoV-2 in Ethiopia
The Ohio State Global One Health initiative (GOHi) is collaborating with the Ethiopian Public Health Institute (EPHI), U.S. Centers for Disease and Control (CDC), Africa CDC and World Health Organization (WHO) to carry out a cross-sectional, population-based sero-prevalence study on COVID-19. This study will involve more than 14,000 households in Ethiopia.
Risk ranking exercise conducted on food hazards in Ethiopia
Ethiopia bears a significant burden of foodborne illnesses. The Global One Health initiative (GOHi) has been working on the Assessment and Risk Management of Foodborne Illnesses (TARTARE) – a food safety project – since 2019. The overarching goal of this project is to reduce morbidity and mortality from foodborne diseases.
RT-PCR training for influenza testing labs in Ethiopia
The Ohio State Global One Health initiative (GOHi), in partnership with U.S. Centers for Disease Control (CDC), has established four severe acute respiratory infection (SARI)/influenza-like illness (ILI) testing laboratories in Ethiopia, including regional and sub-regional labs in Addis Ababa, Bahir Dar, Adama and Arba Minch.
GOHi provides NGS training in Ethiopia
The Ethiopian Public Health Institute (EPHI) has established a Genomic Core Facility operated by a team of 12 experts from different divisions. This facility aims to fill in the gaps in genomic workflows and strengthen the capacity for genomic data analysis.
GOHi supports causality assessment in Ethiopia
Ohio State’s Global One Health initiative (GOHi) is supporting the Ethiopian Food and Drug Authority (EFDA) in undertaking a causality assessment of adverse events following immunizations (AEFI), mainly with COVID-19 vaccines, that were reported to the pharmacovigilance system. As part of GOHi’s continued support to the EFDA, 30 participants – including members of the pharmacovigilance advisory committee, experts of the pharmacovigilance team at EFDA and advisors – conducted the assessment on July 19 and 20.
GOHi provided training on respiratory specimen management
The Global One Health initiative (GOHi) has continued supporting the Ethiopian government in strengthening the national severe acute respiratory infection (SARI)/influenza-like illness (ILI) surveillance system through a range of capacity-building activities. A recently conducted joint supportive supervision on ILI/SARI sentinel sites indicated a critical gap in the trained workforce on sample collection at the facility level.
GOHi provided training on IPC practices
The Global One Health initiative (GOHi) provided a three-day training in June for healthcare workers from Tikur Anbessa Specialized Hospital (Addis Ababa University) and Zewditu Memorial Hospital on Infection Prevention and Control (IPC) practices.
GOH, LLC conducted AMR specimen collection TOT training
As a continuation of the Global One Health initiative's (GOHi) commitment to combating antimicrobial resistance (AMR) in Ethiopia, GOHi collaborated with the Ethiopian Public Health Institute (EPHI) to deliver master Training of Trainers (TOT) training in clinical specimen collection for participants selected from AMR-surveillance-participating health facilities in March 2022.
Capacity-building training on causality assessment of adverse events
The Global One Health initiative (GOHi), the Ethiopian Food and Drug Authority (EFDA) and the World Health Organization Ethiopia Office (WHO-ET), collaborated and delivered capacity-building training on the investigation and causality assessment of Adverse Events Following Immunization (AEFI).